GlassScriptPhysician profile
Elizabeth Branson
NPI 1023587516
$3,918.59
in general payments reported to CMS, 2019-2025
20 companies · $3,008 in 2025
The $3,008 reported for 2025 was more than what 97% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $57.09 · 2024: $854 · 2025: $3,008.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,712 · Education: $150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,711.52 |
| Education | $149.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $860.74 | 2024-2025 | |
| Lilly USA, LLC | $698.18 | 2024-2025 | Taltz, Zepbound |
| Amgen INC. | $478.36 | 2024-2025 | Otezla, Enbrel, Uplizna |
| Pfizer INC. | $350.47 | 2024-2025 | |
| Janssen Biotech, INC. | $333.00 | 2024-2025 | Tremfya |
| Mallinckrodt Hospital Products INC. | $237.70 | 2025 | Acthar |
| Boehringer Ingelheim Pharmaceuticals, INC. | $169.86 | 2024-2025 | Ofev |
| Ucb, INC. | $160.91 | 2024-2025 | Bimzelx |
| Radius Health, INC. | $134.49 | 2024-2025 | Tymlos |
| Astrazeneca Pharmaceuticals LP | $77.26 | 2025 | Saphnelo |
| Aurinia Pharma U.S., INC. | $71.48 | 2025 | Lupkynis |
| Fresenius Kabi USA, LLC | $66.35 | 2025 | |
| Vertex Pharmaceuticals Incorporated | $64.01 | 2025 | |
| Boston Scientific Corporation | $57.09 | 2021 | |
| Tonix Medicines, INC. | $33.87 | 2025 | Tonmya |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alvogen INC | $31.17 | 2024-2025 | Teriparatide |
| Novartis Pharmaceuticals Corporation | $27.46 | 2024 | |
| Sobi, INC | $26.04 | 2025 | |
| Organon LLC | $23.12 | 2025 | |
| Depuy Synthes Sales INC. | $17.03 | 2025 | Orthovisc, Monovisc |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elizabeth Branson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.